Reportable Segments | Segment Information: Our three reportable segments include: (1) Lithium; (2) Bromine Specialties; and (3) Catalysts. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This business structure aligns with the markets and customers we serve through each of the segments. This structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. Summarized financial information concerning our reportable segments is shown in the following tables. The “All Other” category includes only the fine chemistry services business that does not fit into any of our core businesses. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs. The Company’s chief operating decision maker uses adjusted EBITDA (as defined below) to assess the ongoing performance of the Company’s business segments and to allocate resources. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items in a balanced manner and on a segment basis. These non-recurring or unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP. Three Months Ended Nine Months Ended 2019 2018 2019 2018 (In thousands) Net sales: Lithium $ 330,386 $ 270,928 $ 947,030 $ 886,523 Bromine Specialties 256,267 232,616 760,752 678,769 Catalysts 261,346 251,139 779,295 796,822 All Other 31,748 23,065 109,786 90,978 Corporate — — — 159 Total net sales $ 879,747 $ 777,748 $ 2,596,863 $ 2,453,251 Adjusted EBITDA: Lithium $ 127,459 $ 113,629 $ 384,854 $ 386,260 Bromine Specialties 88,814 78,585 248,743 217,921 Catalysts 66,944 62,602 193,890 205,534 All Other 10,448 3,968 28,931 7,729 Corporate (39,314 ) (23,702 ) (114,300 ) (75,082 ) Total adjusted EBITDA $ 254,351 $ 235,082 $ 742,118 $ 742,362 See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands): Lithium Bromine Specialties Catalysts Reportable Segments Total All Other Corporate Consolidated Total Three months ended September 30, 2019 Net income (loss) attributable to Albemarle Corporation $ 102,136 $ 75,224 $ 54,345 $ 231,705 $ 8,305 $ (84,940 ) $ 155,070 Depreciation and amortization 25,212 12,448 12,599 50,259 2,143 2,085 54,487 Acquisition and integration related costs (a) — — — — — 4,114 4,114 Interest and financing expenses — — — — — 11,108 11,108 Income tax expense — — — — — 25,341 25,341 Non-operating pension and OPEB items — — — — — (551 ) (551 ) Other (b) 111 1,142 — 1,253 — 3,529 4,782 Adjusted EBITDA $ 127,459 $ 88,814 $ 66,944 $ 283,217 $ 10,448 $ (39,314 ) $ 254,351 Three months ended September 30, 2018 Net income (loss) attributable to Albemarle Corporation $ 90,313 $ 67,967 $ 50,491 $ 208,771 $ 1,978 $ (81,004 ) $ 129,745 Depreciation and amortization 23,370 10,618 12,111 46,099 1,990 1,618 49,707 Restructuring and other (c) — — — — — 3,724 3,724 Acquisition and integration related costs (a) — — — — — 4,305 4,305 Interest and financing expenses — — — — — 12,988 12,988 Income tax expense — — — — — 33,167 33,167 Non-operating pension and OPEB items — — — — — (2,195 ) (2,195 ) Legal accrual (d) — — — — — (1,017 ) (1,017 ) Other (e) (54 ) — — (54 ) — 4,712 4,658 Adjusted EBITDA $ 113,629 $ 78,585 $ 62,602 $ 254,816 $ 3,968 $ (23,702 ) $ 235,082 Nine months ended September 30, 2019 Net income (loss) attributable to Albemarle Corporation $ 312,609 $ 212,320 $ 156,328 $ 681,257 $ 22,629 $ (261,049 ) $ 442,837 Depreciation and amortization 71,669 35,281 37,562 144,512 6,302 5,904 156,718 Acquisition and integration related costs (a) — — — — — 14,388 14,388 Gain on sale of property (f) — — — — — (11,079 ) (11,079 ) Interest and financing expenses — — — — — 35,295 35,295 Income tax expense — — — — — 93,266 93,266 Non-operating pension and OPEB items — — — — — (1,810 ) (1,810 ) Other (b) 576 1,142 — 1,718 — 10,785 12,503 Adjusted EBITDA $ 384,854 $ 248,743 $ 193,890 $ 827,487 $ 28,931 $ (114,300 ) $ 742,118 Nine months ended September 30, 2018 Net income (loss) attributable to Albemarle Corporation $ 315,939 $ 187,176 $ 387,038 $ 890,153 $ 1,659 $ (327,846 ) $ 563,966 Depreciation and amortization 71,760 30,745 37,201 139,706 6,070 4,735 150,511 Restructuring and other (c) — — — — — 3,724 3,724 Gain on sale of business (g) — — (218,705 ) (218,705 ) — — (218,705 ) Acquisition and integration related costs (a) — — — — — 13,016 13,016 Interest and financing expenses — — — — — 39,834 39,834 Income tax expense — — — — — 133,630 133,630 Non-operating pension and OPEB items — — — — — (6,596 ) (6,596 ) Legal accrual (d) — — — — — 27,027 27,027 Environmental accrual (h) — — — — — 15,597 15,597 Albemarle Foundation contribution (i) — — — — — 15,000 15,000 Other (e) (1,439 ) — — (1,439 ) — 6,797 5,358 Adjusted EBITDA $ 386,260 $ 217,921 $ 205,534 $ 809,715 $ 7,729 $ (75,082 ) $ 742,362 (a) Included acquisition and integration related costs relating to various significant projects. For the three-month and nine-month periods ended September 30, 2019 , $4.1 million and $14.4 million was recorded in Selling, general and administrative expenses. For the three-month and nine-month periods ended September 30, 2018 , $0.9 million and $2.9 million was recorded in Cost of goods sold, respectively, and $3.4 million and $10.2 million was recorded in Selling, general and administrative expenses, respectively. (b) Included amounts for the three months ended September 30, 2019 recorded in: ▪ Cost of goods sold - $0.1 million related to non-routine labor and compensation related costs in Chile that are outside normal compensation arrangements. ▪ Selling, general and administrative expenses - $1.1 million of a write-off of uncollectable accounts receivable from a terminated distributor in the Bromine Specialties segment. ▪ Other (expenses) income, net - $3.1 million of unrecoverable vendor costs outside the operations of the business related to the construction of the future Kemerton production facility, as well as a net loss of $0.4 million primarily resulting from the settlement of legal matters related to previously disposed businesses or recorded in purchase accounting. Included amounts for the nine months ended September 30, 2019 recorded in: ▪ Cost of goods sold - $0.6 million related to non-routine labor and compensation related costs in Chile that are outside normal compensation arrangements. ▪ Selling, general and administrative expenses - Expected severance payments to be made in 2019 as part of a business reorganization plan of $5.3 million , with the unpaid balance recorded in Accrued expenses as of September 30, 2019, $1.0 million of shortfall contributions for our multiemployer plan financial improvement plan, and $1.1 million of a write-off of uncollectable accounts receivable from a terminated distributor in the Bromine Specialties segment. ▪ Other (expenses) income, net - $3.1 million of unrecoverable vendor costs outside the operations of the business related to the construction of the future Kemerton production facility, a net loss of $0.4 million primarily resulting from the settlement of legal matters related to previously disposed businesses or recorded in purchase accounting, and $0.9 million of a net loss primarily resulting from the revision of indemnifications and other liabilities related to previously disposed businesses. (c) Severance payments as part of a business reorganization plan, recorded in Selling, general and administrative expenses. (d) Included in Other (expenses) income, net for the three-month and nine-month periods ended September 30, 2018 is a gain of $1.4 million and an expense of $16.2 million , respectively, resulting from a jury rendered verdict against Albemarle related to certain business concluded under a 2014 sales agreement for products that Albemarle no longer manufactures and expenses of $0.4 million and $10.8 million , respectively, resulting from a settlement of a legal matter related to guarantees from a previously disposed business. (e) Included amounts for the three months ended September 30, 2018 recorded in: ▪ Cost of goods sold - $3.8 million for the write-off of fixed assets related to a major capacity expansion in our Jordanian joint venture. ▪ Selling, general and administrative expenses - $0.1 million gain related to a refund from Chilean authorities due to an overpayment made in a prior year, partially offset by a $1.2 million contribution, using a portion of the proceeds received from the Polyolefin Catalysts Divestiture, to schools in the state of Louisiana for qualified tuition purposes. This contribution is significant in size and is intended to provide long-term benefits for families in the Louisiana community. ▪ Other (expenses) income, net - $0.2 million gain related to the revision of previously recorded expenses of disposed businesses. Included amounts for the nine months ended September 30, 2018 recorded in: ▪ Cost of goods sold - $4.9 million for the write-off of fixed assets related to a major capacity expansion in our Jordanian joint venture. ▪ Selling, general and administrative expenses - $1.5 million gain related to a refund from Chilean authorities due to an overpayment made in a prior year, partially offset by a $1.2 million contribution, using a portion of the proceeds received from the Polyolefin Catalysts Divestiture, to schools in the state of Louisiana for qualified tuition purposes. This contribution is significant in size and is intended to provide long-term benefits for families in the Louisiana community. ▪ Other (expenses) income, net - $0.8 million related to the revision of previously recorded expenses of disposed businesses. (f) Gain recorded in Other (expenses) income, net related to the sale of land in Pasadena, Texas not used as part of our operations. (g) Gain related to the sale of the Polyolefin Catalysts Divestiture, which closed in the second quarter of 2018. (h) Increase in environmental reserve to indemnify the buyer of a formerly owned site recorded in Other (expenses) income, net. As defined in the agreement of sale, this indemnification has a set cutoff date in 2024, at which point we will no longer be required to provide financial coverage. (i) Included in Selling, general and administrative expenses is a charitable contribution, using a portion of the proceeds received from the Polyolefin Catalysts Divestiture, to the Albemarle Foundation, a non-profit organization that sponsors grants, health and social projects, educational initiatives, disaster relief, matching gift programs, scholarships and other charitable initiatives in locations where our employees live and operate. This contribution is in addition to the ordinary annual contribution made to the Albemarle Foundation by the Company, and is significant in size and nature in that it is intended to provide more long-term benefits in the communities where we live and operate. |